Merit Medical Launches Expanded Maestro® Microcatheter Line
10 Octobre 2023 - 3:25PM
Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global
manufacturer and marketer of healthcare technology, today announced
the expansion of its Maestro Microcatheter product line to now
include a new longer length for radial embolization
procedures.
The Maestro is part of a comprehensive offering of embolotherapy
solutions, which includes Embosphere® Microspheres, the most widely
studied and clinically utilized round embolic on the market.
Embolization is a minimally invasive procedure that blocks one or
more blood vessels or abnormal vascular channels to treat a number
of clinical conditions. The new 165-cm Maestro length will be
available in 2.1F, 2.4F, 2.8F, and 2.9F catheter diameters to
support a broad range of embolization procedures.
“Merit Maestro’s longer length is ideal for radial access,” said
Mary Costantino, MD, interventional radiologist at Advanced
Vascular Centers in Oregon, and a paid consultant of Merit. “Radial
access can streamline patient care by enabling some patients to be
treated in outpatient and office-based lab settings where they can
return home on the day of their procedure, improving patient
satisfaction and saving healthcare resources.”
“The Maestro expansion continues our strong legacy of advancing
solutions for our healthcare partners,” said Fred P. Lampropoulos,
Merit Medical’s Chairman and CEO. “We are especially pleased to
bring new technology to our embolotherapy portfolio. Through
ongoing innovation, as well as the reinvention of existing
products, we enhance the alignment of our portfolios with our
mission of improving lives around the globe.”
The Maestro Microcatheter is compatible with coils up to 0.018"
and embolics up to and including 900 µm. Three tip designs are
available, including a swan neck designed to seat the catheter in
the vessel, reducing the recoiling effect of the microcatheter as
embolic is delivered. A hydrophilic coating aids in smooth tracking
through tortuous anatomy.
Merit is a market leader in radial access with a portfolio that
includes the recently launched PreludeSYNC EZ™ Radial Compression
Device, PreludeSYNC Distal™ Radial Compression Device, and Prelude
IDeal™ Hydrophilic Sheath Introducer.
Radial artery access is a minimally invasive approach to
diagnosing and treating a wide range of medical conditions. Through
a small hole in the wrist, a catheter is inserted into the radial
artery. Under imaging guidance, the catheter is then threaded
through the body’s network of blood vessels to the location needing
treatment. Compared to femoral access procedures, or those
performed through the femoral artery in the groin, benefits of
radial access include fewer bleeding complications, improved
patient comfort, and decreased procedure costs. Learn
more about Merit Maestro Microcatheters.
ABOUT MERIT MEDICAL Founded in 1987, Merit Medical Systems, Inc.
is engaged in the development, manufacture, and distribution of
proprietary disposable medical devices used in interventional,
diagnostic, and therapeutic procedures, particularly in cardiology,
radiology, oncology, critical care, and endoscopy. Merit serves
client hospitals worldwide with a domestic and international sales
force and clinical support team totaling more than 700 individuals.
Merit employs approximately 7,100 people worldwide.
TRADEMARKS Unless noted otherwise, trademarks and registered
trademarks used in this release are the property of Merit Medical
Systems, Inc., its subsidiaries, or its licensors.
CONTACTS PR/Media Inquiries Sarah Comstock Merit
Medical +1-801-432-2864 | sarah.comstock@merit.com
INVESTOR INQUIRIES Mike Piccinino, CFA, IRC Westwicke
- ICR +1-443-213-0509
| mike.piccinino@westwicke.com
1. O’Riordan. 2022. “Radial Access for Angiography and PCI on
the Rise in the US.” TCTMD (Mar
16). https://www.tctmd.com/news/radial-access-angiography-and-pci-rise-us
Merit Medical Systems (NASDAQ:MMSI)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Merit Medical Systems (NASDAQ:MMSI)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024